ICCCImmucell Corp

CSNasdaq (XNAS)·USD

Identity

Security key: 16860
Ticker: ICCC
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1987-07-08
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: ICCC

Detail

Enriched 2026-08-14 20:47

Market cap: $99,333,853.02
Shares outstanding (class): 9,046,799
Shares outstanding (weighted): 9,046,799
SIC: 2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees: 73
Location: PORTLAND, ME
Homepage: https://www.immucell.com
Description: ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Market cap and share counts drift.

Funds holding this security

6 funds · 6 positions · $1.78M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$1.15M	0.00%	181,077 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$501.7K	0.00%	79,250 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$105.7K	0.01%	16,704 NS	FIGI
Small Cap Core Fund Northern Funds	—	$12.7K	0.00%	2,005 NS	FIGI
LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$9.0K	0.00%	1,420 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$6.9K	0.00%	1,094 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERICCC
FIGI_COMPOSITEBBG000BLQ5Q2
FIGI_SHARE_CLASSBBG001S5S3P1
CIK0000811641
ISINUS4525253062
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Life Sciences Tools
Source: LLMunreviewed
Self-reported confidence: 0.7
Model: deepseek
Rationale: SIC 2835 indicates in vitro and in vivo diagnostic substances, aligning with healthcare life science tools.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.